JMS Co Ltd operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JMS Co Ltd with three other
companies in this sector in Japan:
Asahi Intecc Co., Ltd.
sales of 42.71 billion Japanese Yen [US$380.54 million]
of which 80%
Kawasumi Laboratories, Incorporated
(24.73 billion Japanese Yen [US$220.31 million]
of which 55%
was Extracorporeal Circulation-Related), and
(17.17 billion Japanese Yen [US$152.96 million]
JMS Co Ltd reported sales of ¥55.57 billion (US$495.16 million)
March of 2017.
decrease of 3.6%
versus 2016, when the company's sales were ¥57.64 billion.
Contributing to the drop in overall sales was the 20.5% decline
in Operating Segment-America, from ¥3.13 billion to ¥2.49 billion.
There were also decreases in sales in
Operating Segment-Southeast Asia (down 14.1% to ¥8.93 billion)
Operating Segment-Germany (down 11.8% to ¥2.93 billion)
Operating Segment-China (down 3.9% to ¥1.62 billion)
Others (down 14.1% to ¥1.61 billion)
However, these declines were partially offset by the increase in sales of
Operating Segment-Japan (up 2.0% to ¥38.00 billion)